These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10345144)

  • 1. Spine studies to remain part of bone analysis.
    Diagn Imaging (San Franc); 1998 Nov; Suppl Bone Mass():6. PubMed ID: 10345144
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.
    Palomba S; Orio F; Russo T; Colao A; Lombardi G; Zullo F
    Fertil Steril; 2004 Feb; 81(2):476-8. PubMed ID: 14967398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern osteoporosis therapy. Only once weekly against osteoporosis].
    MMW Fortschr Med; 2001 Jul; 143(28-29):52-3. PubMed ID: 11499150
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
    Schnitzer T; Bone HG; Crepaldi G; Adami S; McClung M; Kiel D; Felsenberg D; Recker RR; Tonino RP; Roux C; Pinchera A; Foldes AJ; Greenspan SL; Levine MA; Emkey R; Santora AC; Kaur A; Thompson DE; Yates J; Orloff JJ
    Aging (Milano); 2000 Feb; 12(1):1-12. PubMed ID: 10746426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate in the treatment of postmenopausal osteoporosis.
    Hosking DJ; Favus M; Yates AJ
    Int J Clin Pract Suppl; 1999 Apr; 101():27-35. PubMed ID: 12669738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of special studies with alendronate.
    McClung M
    Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapies for osteoporosis.
    Jamal SA
    J Am Pharm Assoc (2003); 2004; 44(2):119; author reply 119. PubMed ID: 15098843
    [No Abstract]   [Full Text] [Related]  

  • 8. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
    Eviö S; Tarkkila L; Sorsa T; Furuholm J; Välimäki MJ; Ylikorkala O; Tiitinen A; Meurman JH
    Oral Dis; 2006 Mar; 12(2):187-93. PubMed ID: 16476042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
    Jiang Y; Li M; Xia W; Xing X; Yu W; Tian J; Meng X; Zhou X
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1254-6. PubMed ID: 12425805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in spine and radius bone density during long-term hormone replacement.
    Blake JM; Ryan ED; Beaumont LF; Webber CE
    Can J Physiol Pharmacol; 1999 Jul; 77(7):505-9. PubMed ID: 10535710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for a random measurement of 24-hour urine calcium excretion in the determination of calcium supplementation in osteoporotic postmenopausal women using alendronate?
    Pines A; Weisman Y; Ayalon D; Shapira I
    Gynecol Endocrinol; 2005 Jan; 20(1):45-7. PubMed ID: 15969246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.
    Ascott-Evans BH; Guanabens N; Kivinen S; Stuckey BG; Magaril CH; Vandormael K; Stych B; Melton ME
    Arch Intern Med; 2003 Apr; 163(7):789-94. PubMed ID: 12695269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ; Im JA; Kim SH
    Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
    Ozdemir F; Rodoplu M
    Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.